Oncotarget published this trending editorial perspective on March 21, 2023 in Volume 14, entitled, “Cancer-associated fibroblasts: challenges and opportunities" by researchers from the Department of Biomedical Engineering, The University of Akron, Akron, OH. DOI - https://doi.org/10.18632/oncotarget.28385 (PDF) Correspondence to - Hossein Tavana - tavana@uakron.edu Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28385 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - fibroblasts, cancer-associated fibroblasts, tumor microenvironment, therapeutic targeting About Oncotarget Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957
Cancer ResearchCell ScienceMolecular Biology